Carnival Corporation & plc (NYSE:CCL) (NYSE:CUK) delivered a decisive earnings beat and reinstated its dividend after posting record fourth-quarter profit and cash flow. Carnival reported fourth-quarter net income of $422 million, or 31 cents per share, up nearly 40% from…
In the current session, FS KKR Capital Inc. (NYSE:FSK) is trading at $14.96, after a 0.07% drop. Over the past month, the stock fell by 5.47%, and in the past year, by 31.20%. With performance like this, long-term shareholders are…
Cassava Sciences Inc. (NASDAQ:SAVA) received a formal letter from the U.S. Food and Drug Administration (FDA) related to the company’s trial for simufilam Following previously reported communications with the FDA regarding Cassava’s investigational new drug application and proposed proof-of-concept clinical…
Betting markets are increasingly assigning a non-trivial probability that the U.S. could launch a military operation in Venezuela sooner than many investors expect, even as oil prices continue to trade as if geopolitical risk in Latin America is negligible. On…
Investors with a lot of money to spend have taken a bullish stance on Uber Technologies (NYSE:UBER). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here…
In the current market session, Kohl's Inc. (NYSE:KSS) stock price is at $22.40, after a 1.19% drop. However, over the past month, the company's stock increased by 42.58%, and in the past year, by 56.75%. Shareholders might be interested in…
Autozi Internet Technology (Global) Ltd. (NASDAQ:AZI) stock rose Friday after the company disclosed a significant strategic investment. The automotive aftermarket platform confirmed a sizable equity commitment from a global technology-focused investor. Autozi said strategic investor CDIB, also known as Catalyst…
CAMP4 Therapeutics Corporation (NASDAQ:CAMP) on Thursday entered into a strategic research, collaboration, and license agreement with GSK Plc (NYSE:GSK). The collaboration aims to identify and develop antisense oligonucleotide (ASO) drug candidates for multiple gene targets relevant to neurodegenerative and kidney…
Paychex, Inc. (NASDAQ:PAYX) reported strong fiscal second-quarter results, highlighted by an 18% year-over-year increase in total revenue to $1.557 billion. Adjusted diluted earnings per share were $1.26, up from $1.14 a year earlier, while GAAP diluted earnings per share were…
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.49% to 48,188.36 while the NASDAQ jumped 1.03% to 23,243.38. The S&P 500…